Highbridge Capital Management LLC Coherus Bio Sciences, Inc. Transaction History

Highbridge Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$10.25 - $17.45 $3.84 Million - $6.54 Million	-375,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$9.1 - $13.7 $3.41 Million - $5.14 Million	375,000 New	375,000 $4.14 Million
Q4 2017 Feb 14, 2018	SELL	$8.35 - $14.4 $283,115 - $488,246	-33,906 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$11.1 - $14.5 $110,445 - $144,275	-9,950 Reduced 22.69%	33,906 $453,000
Q2 2017 Aug 14, 2017	BUY	N/A	43,856	43,856 $630,000

130

67.8M

1.68M

91.8K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $70.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.